PBRM1 and nonpapillary renal cell carcinoma: Treatment with PRT1419 for 72 hours potently inhibited 3D cell proliferation and induced apoptotic cell death in a dose-dependent manner in PBRM1-mutant ccRCC cell lines but not WT (Figures 1C–E).